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Plain language summary
Almost all older adults in the United
States have prescription drug insurance,
but many still cannot afford them.
This is most true for those who take
many daily prescriptions, do not have
prescription insurance, and have a low
income.

Implications for managed
care pharmacy
Among older adults in the United States,
policies that reduce the out-of-pocket
expenditures for prescription drugs
appeared to reduce the burden of these
expenditures for older adults. Managed
care policymakers should consider
policies that reduce out-of-pocket costs
for older adults in an effort to promote
medication access. Such policies may
enable older adults to reallocate
funds for vital expenses like food and
shelter, especially for older adults from
vulnerable populations (ie, low income,
underrepresented minority).
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ABSTRACT
BACKGROUND: Cost-related nonadherence
compromises successful and effective management of chronic disease. The Medicare
Modernization Act of 2003 (MMA) and Patient
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Protection and Affordable Care Act of 2010

(“donut hole”) created by the MMA was fully

(ACA) aimed to increase the affordability of

closed in 2020 by the ACA.

outpatient prescription drugs for older adults

OBJECTIVES: To (1) describe prescription
drug coverage and financial hardship from
purchasing prescription drugs among older

(older than age 64 years). The Medicare Part
D prescription drug insurance coverage gap
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American adults for 2021, (2) compare these results with findings
from data collected before the MMA and during the progressive
elimination of the Medicare Part D coverage gap, and (3) compute
the likelihood for financial hardship from purchasing prescription
drugs using variables for year, prescription drug insurance coverage,
health-related information, and demographics.
METHODS: Data were obtained from 4 nationally distributed, crosssectional surveys of older adults to track coverage for and financial
hardship from purchasing prescription drugs. Surveys in 1998 and
2001 were mailed to national random samples of US seniors. Of 2,434
deliverable surveys, 700 (29%) provided useable data. Data were
collected in 2015 and 2021 via online surveys sent to samples of US
adults. Of 27,694 usable responses, 4,445 were from older adults.
Descriptive statistics and logistic regression analyses described relationships among financial hardship and demographics, diagnoses,
and daily prescription drug use.
RESULTS: Five percent of older adults lacked prescription drug coverage in 2021, continuing a downward trend from 32% in 1998, 29%
in 2001, and 9% in 2015. Contrastingly, 20% of older adults reported
financial hardship from prescription drug purchases in 2021, bending an upward trend from 19% in 1998, 31% in 2001, and 36% in 2015.
Financial hardship from purchasing prescription drugs was more likely to be reported by older adults lacking prescription drug insurance,
taking multiple medications daily, and having a low annual household income across all survey years. The latter 2 of these 3 factors
were still predictive of financial hardship from purchasing prescription drugs among older adults with prescription drug insurance.
CONCLUSIONS: Financial hardship from purchasing prescription
drugs is still experienced by many older adults after the full
implementation of the MMA and ACA. Lacking prescription drug
coverage, taking more than 5 prescription drugs daily, and a
low annual household income may increase the likelihood of
experiencing this financial hardship. Pharmacists can be a resource
for older adults making choices about their prescription drug
coverages and purchases.

The creation of Medicare Part D by the Medicare
Modernization Act of 2003 (MMA) and the Patient
Protection and Affordable Care Act (ACA) in 2010 represent
the 2 major legislative actions in the United States over the
past 2 decades with aims to increase the affordability of
outpatient prescription drugs for older adults (older than
age 64 years) through federally approved, private coverage plans. The inability to pay for prescription drugs is an
important determinant of medication adherence that may
lead patients to ration or split doses, delay refills or new
prescriptions, and even stop taking medications altogether.1
Cost-related nonadherence compromises the therapeutic
effectiveness in managing most chronic diseases, persists

even when patients cut back on basic health-related social
needs, and consequently leads to higher preventable health
care expenditures.1–5
In 2006, Medicare Part D began providing older adults
with the option to enroll in outpatient prescription drug
plans that progressed through 4 sequential phases each
year: (1) out-of-pocket deductible (patient pays full amount
owed up to deductible threshold before transitioning to the
next phase of the plan); (2) initial coverage (patient pays a
copay or coinsurance based on drug tier, with the insurance carrier covering the remainder up to predetermined
annual threshold, and transitions to the next phase when
the amount is exceeded); (3) out-of-pocket coverage gap
(ie, the coverage gap, or “donut hole,” is the prescription
cost range in which patients again paid the full amount up
until a predetermined annual threshold prior to the ACA.
Since the ACA passed, patients have progressively received
coverage from insurance, plateauing in 2020 at 75% until
the threshold is met and transitions to the next phase of
coverage); and (4) catastrophic coverage (patients pay 5%
coinsurance on their prescription drugs for the remainder
of the calendar year). In the years that followed, evidence
from several studies suggested an association between
cost-related nonadherence and the donut hole phase that
diminished potential health outcomes and overall cost
savings.4,6–11 Sections of the ACA attempted to address these
concerns by gradually reducing the out-of-pocket costs for
enrolled older adults in the Medicare Part D coverage gap
using coinsurance mechanisms from 100% in 2010 to 25%
in 2020.12-13 The Department of Health and Human Services
estimate that changes to Medicare from the ACA have
saved almost 12 million older adults more than $26 billion
dollars on out-of-pocket prescription drug expenditures as
of 2017.14
Results from 3 cross-sectional national surveys of US
older adults from 1998, 2001, and 2015 showed an increase
in financial hardship from purchasing prescription drugs
between the years prior to passage of the MMA and halfway
through the implementation of the ACA (Medicare Part D
coverage gap out-of-pocket costs: 45% brand name and
65% generic). The increase concurred with a proportional
growth in older adults with prescription drug coverage,
suggesting that cost-sharing mechanisms affect financial hardship from prescription drug purchases, which is
linked to cost-related nonadherence and poorer health
outcomes.15,16
This study’s objectives were to (1) describe prescription
drug coverage and financial hardship from purchasing prescription drugs among older adults in the United States for
2021, (2) compare these results with findings from previous
surveys before the passage of the MMA (1998 and 2001) and
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FIGURE 1

Timeline of Surveys Relative to the MMA, ACA, and the Donut Hole

Survey 1

Survey 2

Medicare Part D
implemented

ACA passed

Survey 3

Donut hole
closed
Survey 4

1998

2001

2006

2010

2015

2020

Donut hole
opened

Donut hole
subsidy:
$250

Donut hole
subsidy:
55% brand
35% generic

Donut hole
subsidy:
75% brand
75% generic

2021

ACA = Patient Protection and Affordable Care Act; MMA = Medicare Modernization Act of 2003

during the progressive elimination of the Medicare Part D
coverage gap (2015), and (3) compute the likelihood for
experiencing financial hardship from purchasing prescription drugs by survey year, prescription drug insurance
coverage, health-related information, and demographics.

Methods
DATA COLLECTION
The timing of data collected from each respective survey
relative to the MMA, the ACA, and the laws’ effect on the
Medicare Part D coverage gap are presented in Figure 1. A
modified Dillman mailed survey method (ie, 3 recruitment
contacts instead of the recommended 5) was used to collect data prior to the passage of the MMA from national
random samples of US adults in 1998 (n = 1,570) and 2001
(n = 864).17,18 The 1998 survey produced a relatively low, 29%
response rate that was improved in 2001 by adding survey tracking numbers, allowing targeted follow-up mailers
to nonresponders. Of the 700 survey responses from 1998
and 2001 with usable data, 87 (12%) were missing responses
for income; therefore, a logistic regression equation was
developed from the remaining 613 respondents to predict
whether a respondent was more appropriately coded with
an income “less than $15,000” or “$15,000 or more” (ie, representative poverty thresholds of survey time periods).19
The imputation model used the median household income
for the zip code of the participant responding when fewer
than 5 percent of all items were unanswered throughout the
survey. These resulting imputed values were also included
in this study’s analysis.
Data from 2015 were obtained between April and June
from the National Consumer Survey on the Medication
Experience and Pharmacists’ Roles (NCSME-15), a selfadministered online survey that contained questions
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enabling comparison with data collected in 1998 and 2001.
Qualtrics Panels administered the NCSME-15 to prospective respondents from panels that were screened and
targeted to fulfill preestablished demographic quotas for
location, age, and sex that were representative of the United
States. The process yielded usable responses from 26,173
participants, of whom 3,933 were older adults (older than
age 64 years) and therefore included in this analysis. The
same process and administrator were used to generate data
for the 2021 NCSME, which collected 1,521 usable responses
between April 16th and 30th, 2021, that included 512 older
adults.
Given that the samples of older adults from 1998 (n = 365),
2001 (n = 335), and 2021 (n = 512) were approximately onetenth the size of those from 2015 (n = 3,933), 3 separate 10%
random subsamples (n = 378, 393, and 400) were selected
from the latter to balance unequal sample sizes for use in
the comparative analyses of this study.
This study was reviewed and approved by the University
of Minnesota, Office of the Vice President for Research,
Human Research Protection Program Institutional Review
Board (IRB STUDY #1503E66742).

STUDY VARIABLES
Survey participant responses included in the analysis
provided demographic and health-related information representative of variables from the literature related to the
study’s objectives. These were age (n), sex (male/female),
education (less than high school graduate, high school
graduate, some college, associate’s degree, bachelor’s
degree, master’s degree, professional degree, and doctoral degree), marital status (single [never married], single
[separated/divorced], married/partnered, and widowed),
annual household income level (n), race (American Indian,
Asian, Black/African American, Latino/Latina, White,
and other), number of prescription drugs taken daily (n),
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TABLE 1

Comparisons of Respondent Demographics, Prescription Drug Insurance, and Financial Hardship
From Purchasing Prescription Drugs From Surveys in 1998, 2001, 2015, and 2021
Characteristic

1998 (n = 365)

Mean years of agea (range)

74.9 (65-94)

2001 (n = 335) 2015 (n = 3,933)a 2021 (n = 512)
75.2 (65-95)

70.7 (65-99)

72.2 (65-89)

P valueb
< 0.001

Female sex , %

52

45

63

57

< 0.001

Educationb (more than a high school education), %

56

45

76

56

< 0.001

Marital statusc (married), %

63

59

58

65

Incomeb (< $15K/y 1998, 2001; < $20K/y 2015, 2021), %

19

25

16

8

c

0.008a
< 0.001

White race , %

90

83

91

95

< 0.001

Number of prescription drugs taken dailye (average)

2.9

3.5

4.0

4.1

< 0.001

Number of OTC drugs taken dailye (average)

1.0

1.7

1.5

1.7

< 0.001

Proportion with arthritisc, %

39

46

53

47

< 0.001

Proportion with diabetesc, %

12

16

21

24

< 0.001a

68

71

91

95

< 0.001

19

31

36

20

< 0.001

c,d

Prescription drug insurancec, %
Financial hardship due to prescription drug expenditures , %
c

Given 2015 samples sizes were approximately 10 times larger than those from other years, 3 separate 10% subsamples (n = 378, 393, and 400) were independently
analyzed to balance unequal comparisons. The 3 subsamples were stable and produced similar results. Only the marital status and diabetes variables had at least
1 subsample that did not reach statistical significance. Additional detail can be found by referencing citation the number in the references.
b
P < 0.05.
c
Statistical comparison made using chi-square.
d
Analysis of race compared White and non-White respondents given insufficient sample size to make statistical comparisons among all levels of ethnicity and race
collected across the 4 surveys (American Indian, Asian, Black/African American, Latino/Latina, White, and other). Contact the corresponding author for additional
information.
e
Statistical comparison made using analysis of variance.
a

number of over-the-counter drugs taken daily (n), and diagnosis of diabetes (yes/no) and diagnosis of arthritis (yes/
no; 2 chronic conditions associated with other study variables). Respondents were also provided with the following 2
prompts: “Do you have insurance coverage for prescription
drugs?” (yes/no) and “Purchasing medications causes me
financial hardship” (yes/no). The latter prompt used equivocal wording conducive to respondent’s self-perception of
having experienced financial hardship given the subjective
nature of the term.17,19 Each of these variables were present
in all 4 surveys, mixed among dozens of more variables that
varied by survey year. The latter variables were excluded
from data analysis, as they did not connect the study’s
objective in a straightforward way (eg, the relationship
between personality and financial hardship from purchasing prescription medications), and were not uniformly
present across the 4 key data points.

DATA ANALYSIS
Analysis of variance and chi-square t-test statistics were
used to make descriptive comparisons for study variables
among respondents from each respective survey year

(1998, 2001, 2015, and 2021), using logistic regression to
control any demographic differences. The development
of the logistic regression was conducted via a multiplestep process beginning with a univariate analysis of study
variables. The resulting P values that rose to the level of
statistical significance (P < 0.5) were carried over to the
next step of model building. These were age (n), sex (male/
female), education (high school graduate or less and more
than a high school education), income (at or above income
threshold and below income threshold; in 1998 and 2001,
the threshold was $15,000 and increased to $20,000 in
2015 and 2021), race (non-White and White), number of
prescription drugs taken daily (0, 1-2, 2-5, and > 5), number
of over-the-counter drugs taken daily (0, 1-2, 2-5, and > 5),
arthritis (yes/no), prescription drug insurance (yes/no),
and financial hardship (yes/no).
The remaining relationships between variables were
analyzed using logistic regression, with the goodness
of fit evaluated by change in −2 log-likelihood, chisquare model improvements, and parsimony judgments.
Covariates were then dropped from the regression model
to maximize parsimony and explanatory value (eg, age
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60

Results

55
49

50
40
Percentage

group=at or above income threshold). The corresponding
author can be contacted for more specific information
about the study variables and model building process.

Proportion of US Adults Older
Than Age 64 Years Experiencing
Financial Hardship by Year of
Survey and Prescription Drug
Insurance Coverage Status

FIGURE 2

35

34

32

30
22

19

20
12
10
0
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2001

2015

2021

Year
Prescription drug coverage
No prescription drug coverage
All associations statistically significant (P < 0.05) using chi-square analysis.

was a covariate of the number of prescription drugs taken
daily with weaker explanatory relationships with the
dependent). This step-wise development of the logistic
regression models were used to select the most valuable
variables across samples that differed in composition
and context for each year. These were year (reference
group = 1998), number of prescription drugs taken daily
(reference group = 0), income (reference group=at or
above income threshold.), and prescription drug coverage
(reference group = yes). The corresponding author can be
contacted for more specific information about the study
variables and model building process.
Logistic regression was also used to analyze survey
respondents with prescription drug insurance using the
same model building process, given previous work suggesting a weakening relationship between insurance coverage
for prescription drugs and financial hardship from purchasing medications.15 The most valuable variables were year
(reference group = 1998), number of prescription drugs
taken daily (reference group = 0), and income (reference
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From 1,570 delivered surveys in 1998, a total 463 (29%) were
returned and 365 (23%) provided useable responses. The sizable number of nonusable responses prompted the authors
to include a question in a follow-up survey in 2001 to understand the primary reasons behind nonusable responses.
From 864 delivered surveys in 2001, a total 483 (56%) were
returned and 335 (39%) provided usable responses. Of the
148 nonusable responses, 18% stated the intended recipient had deceased, 15% stated the intended recipient was
not physically or mentally capable of responding, 11% did
not provide a reason (ie, left unanswered), 6% stated the
intended recipient had changed addresses, 4% stated the
intended recipient resided in a nursing home or assisted
living facility, and 46% selected “other.” The most common reasons provided by recipients who selected “other”
included not being interested in the survey or feeling it did
not apply to them (eg, not taking prescription drugs and
receiving prescription drugs through the military).

RESPONDENT DEMOGRAPHICS, PRESCRIPTION
DRUG INSURANCE, AND FINANCIAL HARDSHIP
FROM PURCHASING PRESCRIPTION DRUGS
Demographic comparisons among the respondents for
each survey are presented in Table 1 and show some variable differences among the years, although stable and
similar findings were found for the original and subsamples from 2015. The variable differences among each
survey year were controlled using multivariate analytical
tools following the linear regression model building process described in the Methods.
Table 1 shows the proportion of older adults with prescription drug insurance increased between each survey,
from 68% in 1998, 71% in 2001, 91% in 2015, and 95% in 2021
(P < 0.001). However, Table 1 shows a different pattern for the
proportion of older adults experiencing financial hardship
from purchasing prescription drugs, beginning with 19%
in 1998, rising to 31% in 2001 and 36% in 2015, followed by
a decline to 20% in 2021 (P < 0.001). For both variables, the
three 10% randomized subsamples from 2015 were stable
and consistent with each other and the whole sample (a
detailed description of this process and rationale, as well as
results, is presented by Olson et al15).
The proportion of older adults with and without prescription drug insurance reporting financial hardship
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TABLE 2

Logistic Regression Results for Likelihood of US Adults
Older than Age 64 Years Experiencing Financial Hardship
Because of Prescription Drug Expenditures in 1998, 2001,
2015, and 2021 (n = 5,096)
Variable

P value

Odds ratio

95% CI

NA

Survey year
1998 (reference group)

NA

NA

2001

0.004

b

1.7

1.2-2.5

2015a

< 0.001b

2.8

2.1-3.8

2021

0.156

1.3

0.9-1.9

a

Number of prescription drugs taken daily
NA

NA

NA

1-2

0 (reference group)

0.046b

0.8

0.7-1.0

3-5

0.002b

1.4

1.1-1.7

2.5

2.1-3.1

>5

< 0.001

b

Annual household incomec
At or above threshold (reference group)
Below threshold

NA

NA

NA

< 0.001b

2.2

1.9-2.6

NA

NA

NA

< 0.001b

2.5

2.1-3.0

Prescription drug coverage
Yes (reference group)
No

The sample (n = 5,096) does not equal 5,145 because of missing values. The variables presented in this
table reflect a multistep model build for optimizing parsimony and explanatory value from variables
collected across all 4 data collection points. The variables dropped from the model for which findings are
not presented in the table are age, sex, education, marital status, race, number of over-the-counter drugs
taken daily, diagnosis of arthritis, and diagnosis of diabetes.
a
Not a complete sample.
b
P < 0.05.
c
In 1998 and 2001, the annual household income threshold was $15,000. In 2015 and 2021, the threshold
was $20,000.
NA = not applicable.

from purchasing prescription drugs
is depicted by survey year (1998,
2001, 2015, and 2021) in Figure 2. The
proportion of older adults with prescription drug coverage experiencing
financial hardship from purchasing
prescription drugs rose from 12% in
1998 to 22% in 2001 and 35% in 2015
but then fell to 19% in 2021 (P < 0.001).
The proportion of older adults
without prescription drug coverage
experiencing financial hardship from
purchasing prescription drugs also
rose from 34% in 1998 to 55% in 2001
but then fell to 49% in 2015 and 32% in
2021 (P < 0.001).

Table 2 displays the logistic
regression models with the best
goodness of fit, and parsimony for
the likelihood of reporting financial
hardship due to purchasing prescription drugs were the following
variables: year, the number of prescription drugs taken daily, income,
and prescription drug insurance
coverage. When controlling for other
variables in the models, financial
hardship from purchasing prescription drugs was more likely to be
reported by respondents taking 3-5
prescription drugs daily (odds
ratio [OR] 1.4; P = 0.002), more than

5 prescription drugs daily (OR 2.5;
P < 0.001), lacking prescription drug
insurance (OR 2.5; P < 0.001), and
having an annual household income
below the study threshold (OR 2.2;
P < 0.001) at a statistically significant
level. Compared with 1998, financial
hardship from purchasing prescription drugs was more likely to be
reported by respondents in 2001
(OR 1.7; P = 0.004) and 2015 (OR 2.8;
P < 0.001) at a statistically significant
level.
Table 3 shows the logistic regression models with the best goodness
of fit and parsimony for the likelihood
of reporting financial hardship due to
purchasing prescription drugs among
respondents with prescription drug
insurance coverage. When controlling for other variables in the models,
financial hardship from purchasing
prescription drugs was more likely
to be reported by respondents taking
more than 5 prescription drugs daily
(OR 2.2; P < 0.001) and having an annual
household income below the study
threshold (OR 2.1; P < 0.001). Compared
with 1998, financial hardship from
purchasing prescription drugs was
more likely to be reported by respondents in 2001 (OR 1.8; P = 0.03), 2015
(OR 3.8; P < 0.001), and 2021 (OR 1.7;
P = 0.03) at a statistically significant
level. Additionally, the proportion of
older adults in this subgroup who
experienced financial hardship from
purchasing prescription drugs was
12% in 1998, 22% in 2001, 35% in 2015,
and 19% in 2021 (P < 0.05).

Discussion
One in 5 older adults in the United
States experiences financial hardship from purchasing drugs after the
full implementation of 2 major pieces
of legislation designed, in part, to
offer prescription insurance plans
to address this problem. This finding, together with continued growth
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TABLE 3

Logistic Regression Results for Likelihood of US Adults
Older Than Age 64 Years Experiencing Financial Hardship
Because of Prescription Drug Expenditures in 1998, 2001,
2015, and 2021 for Respondents Who Have Prescription
Drug Insurance (n = 4,496)
P value

Odds ratio

1998 (reference group)

NA

NA

NA

2001

0.030b

1.8

1.1-3.1

Variable

95% CI

Survey year

2015a

< 0.001b

3.8

2.5-5.6

2021a

0.03b

1.7

1.1-2.8

NA

NA

Number of prescription drugs taken daily
0 (reference group)

NA

1-2

0.011

3-5

0.072

>5

< 0.001

b

b

0.7

0.6-0.9

1.2

0.9-1.5

2.2

1.7-2.7

NA

NA

2.1

1.8-2.6

Annual household incomec
At or above threshold (reference group)
Below threshold

NA
< 0.001

b

The sample (n = 4,496) does not equal 4,532 because of missing values. The variables presented in this
table reflect a multistep model build for optimizing parsimony and explanatory value from variables
collected across all 4 data collection points. The variables dropped from the model for which findings are
not presented in the table are age, sex, education, marital status, race, number of over-the-counter drugs
taken daily, diagnosis of arthritis, and diagnosis of diabetes.
a
Complete sample.
b
P < 0.05
c
In 1998 and 2001, the annual household income threshold was $15,000. In 2015 and 2021, the threshold
was $20,000.
NA = not applicable.

in proportional enrollment of older
adults in prescription drug insurance
plans across the survey years, suggests that lacking drug coverage is not
a sufficient predictor of cost-related
nonadherence for older adults. The
number of drug prescriptions taken
daily and annual household income
also make for informative predictors,
although the latter is not currently
available in Medicare claims or utilization data. Additionally, it is notable
that multiple medication use, annual
household income, and lacking drug
coverage retained their predictiveness
across the survey years even when
conducted with differing sample compositions and contexts.
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The overarching pattern of
financial hardship from purchasing
medications also indicates that the
creation of Medicare Part D and subsequent closure of the coverage gap
has helped older adults. Survey results
from 2021 show financial hardship
returning to levels and likelihoods just
above those found in 1998 after being
substantially higher in 2001 and 2015.
This recent progress is also notable
given the presence of new, high-cost
specialty drugs and increased prices
for existing drugs that have outpaced
inflation since the implementation of
the MMA.20–22
Although the comparative findings
produced from this analysis do not

enable definitive statements on the
causes of the results, they provide an
ecological heuristic with snapshots
relevant to 2 significant laws passed,
in part, to increase the affordability
of prescription drugs for older adults.
This lens may be informative for
policymakers looking to make future
decisions in the same areas. The findings appear at odds with concerns at
the time of the MMA’s passage that
prescription drug insurance introduced a “moral hazard” (ie, individuals
buy prescriptions they do not need
because of lower out-of-pocket costs)
that would substantially shift purchasing prescription drugs away from
being a “derived demand” (ie, individuals buy prescriptions when needed to
treat illness).23,24 This may be especially
true for older adults in households
with incomes below the poverty line,
who have lower discretionary funds
to begin with. This may represent
a lesson learned for policymakers
interested in further increasing the
affordability of prescription drugs for
older adults. Policies that ignore or
misjudge the nature of economics and
health behaviors may give birth to
or exacerbate avoidable unintended
consequences that compromise or
reverse progress toward its goals.
Beyond prescription drug coverage policies, other contributors to the
observed decrease in reported hardship for older adults from 2015 to 2021
could be learnings by prescribers,
pharmacists, patients, and third-party
firms about ways to save money on
prescription drug purchases. This
may include increased familiarity
with the nuances of Medicare Part D
(eg, phase spending thresholds, low
income subsidies, copayment vs coinsurance, and preferred/listed drugs),
as well as changes in the utilization
of copay cards, charitable assistance,
and point-of-sale discount programs
like GoodRx, OptumPerks, ScriptSave
WellRx, SingleCare, and Walgreen’s
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Prescriptions Savings Club that discount prescription drugs
independent of a patient’s insurance plan.25–30 The recent
decrease in financial hardship from purchasing medications
may also reflect a growing separation between the majority
of older adults utilizing lower-cost generics to manage their
medical needs and a smaller plurality who require high-cost
specialty and biologic prescriptions, which quickly lead
the catastrophic coverage phase in Medicare Part D.31 This
may indicate that although the prevalence of financial
hardship in 2021 may have fallen to near 1998 levels overall,
today’s older adults who experience financial barriers may
be experiencing higher degrees of financial hardship than
their 1998 counterparts.29,32
Pharmacists may be able to provide important support
for older adults making informed choices about their coverage plans and prescription drug purchases that impact
medication adherence and effectiveness. This is especially
true for older adults more likely to experience financial
hardship from purchasing prescription drugs (ie, take
several prescription drugs each day, have a low annual
household income, and lack prescription coverage).
Lower self-reported financial hardship from purchasing
prescription drugs by older adults may have important
implications. Reduced financial hardship likely reduces
cost-related nonadherence, which may increase access
to medications, improve adherence to medications, and
improve medication-related health outcomes. Future
research using Medicare Part D claims data, combined with
Medicare medical utilization data, could examine trends in
medication access, adherence, and outcomes for patients.
Examining these issues by patient race and income level
(not currently provided by Medicare claims and utilization
data) could explore whether reduced financial hardship
benefited more vulnerable populations to a greater extent.
Additionally, future research could explore the relationship
between reduced financial hardship for prescription drugs
and access to other necessities of living, such as food,
shelter, heating, and transportation.

LIMITATIONS
There are some potential limitations to this study inherent
to bias from self-report measurements, as well as sampling and selection methods, that should inform how the
results are interpreted. First, solitary self-report questions were used to collect information about respondents’
status of drug coverage, medication utilization, and experience of financial hardship from purchasing medications.
Instances of poor reliability and bias from self-report measurements in cross-sectional surveys on topics related to
income and health care utilization are well documented.33,34
Furthermore, respondent perceptions of what constitutes

financial hardship were open to wider interpretations than
more granular, multi-item indicators of the cost-related
nonadherence construct. However, the congruity of recent
findings from these respective measures speaks to the face
validity each provides, albeit from different vantage points.35
Bias from sampling and selection represent another
potential study limitation. Previous work has demonstrated
that individuals who are older, in poorer health, and use
more medications may be underrepresented in survey data
because of nonresponse.36,37 However, the data collected in
this study from 2001 also suggest that many older adults
who did not use any daily prescription drugs felt the survey
did not apply to their situation and, therefore, did not
participate. These data also suggested that roughly half of
older adults the from 1998 and 2001 sample who were mailed
surveys and did not respond were deceased, had changed
addresses, or were unable to complete the instrument
because of physical or mental incapacities. The remaining
half of nonresponders from these years were attributed to
a low level of interest in completing the survey or believing
that the survey did not apply to them. The data collected
for 1998 and 2001 also utilized some imputed values for
the income variable, which may have introduced bias of
higher respondent incomes (ie, the median income of most
zip codes was above the income threshold used for this
variable, which approximated the poverty line). However,
this approach was standard practice at the time and is still
used contemporarily when more accurate techniques or
data are not available. It should also be pointed out when
interpreting results that survey respondents identifying as
White were overrepresented in all study years relative to
the US population of older adults, introducing bias affecting
all study variables.38
The data generated from the online, panel surveys in
2015 and 2021 addressed this limitation through dynamic
screening and monitoring of response patterns by Qualtrics
Panels to match characteristics of the US population.
The online format also substantially reduced the lag time
between when samples were selected and surveys were
delivered compared with mailing. However, the transition
to a new data collection approach in the later years may
also have introduced bias.
Finally, the data collected from the 4 survey time points
over the 24-year period could not capture other macrolevel
forces beyond the MMA and ACA that likely impacted financial hardship among older American adults, both in general
and in relation to the purchase of prescription medications.
This includes the US stock market and productivity gains
in the latter half of the 1990s, the following US recession
and September 11th terror attacks, effects from European
austerity measures and the Chinese stock market crash in
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2015, the ongoing COVID-19 pandemic
in 2021, and changes in political leadership, technological innovation, and
workforce dynamics throughout the
entire time period. Additionally, the
relative meaning and experience of
financial hardship are likely different
in 2021 than it was in 1998. However,
despite this significant variation in the
ecological environment over time, the
key variables informing this study’s
models remained stable across each of
the 4 survey time periods.

Conclusions
The proportion of older adults in the
United States carrying prescription
drug coverage appears to have continually risen since the passage and
full implementation of the MMA and
the ACA (68% in 1998, 71% in 2001, 91%
in 2015, and 95% in 2021). However, the
proportion of older adults experiencing financial hardship from purchasing
prescription drugs has not followed
the same trendline (19% in 1998, 31%
in 2001, 36% in 2015, and 20% in 2021).
A sizable proportion of older adults in
2021 remain at risk for cost-related
nonadherence despite the reversal of
perverse incentives addressed by closing the donut hole. Findings show that
the lack of prescription drug coverage,
taking more than 5 prescription drugs
daily, and a low annual household
income may increase the likelihood of
experiencing financial hardship from
purchasing prescription medications.
Prescription drug discount programs
may be enabling older adults to more
affordably
purchase
prescription
medications outside of their managed care insurance. Pharmacists can
be a resource for older adults making
choices about their prescription drug
coverages and purchases.
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